Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-03-04 @ 7:43 PM
Study NCT ID:
NCT02312102
Status:
COMPLETED
Last Update Posted:
2025-06-17
First Post:
2014-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-05
First Submit QC Date:
None
Study First Post Date:
2014-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-12
Last Update Post Date:
2025-06-17
Last Update Post Date Type:
ACTUAL